A Prospective, International, Multicentre Registry of Patients Undergoing Segmental Mandibular Defect Reconstruction After Mandibular Resection for Tumours and Drug-Induced Osteonecrosis: A Study Protocol
Craniomaxillofacial Trauma & Reconstruction · 23.03.2026 · 19 (1) · 17
DOI: 10.3390/cmtr19010017 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Craniomaxillofacial Trauma & Reconstruction, online erschienen am 23.03.2026. Verfasst von Rüdiger M Zimmerer und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, University Hospital Tübingen, 72076 Tübingen, Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AO Foundation, AO Foundation via the AO Innovation Translation Center.
Abstract (Originalsprache)
Segmental mandibular resection may be indicated as a treatment in, for example, advanced stages of oral squamous cell carcinoma (OSCC). Osseous reconstruction of these defects is a fundamental part of static and dynamic masticatory rehabilitation, particularly when dental implants are required. The Segmental Mandibular Defect Reconstruction (SMDR) Registry aims to generate real-world evidence on SMDR through an international, prospective, multicentre case series designed as a registry. While OSCC is a common indication for segmental mandibular resection, the SMDR Registry also aims to capture outcomes for rarer mandibular conditions and the increasing number of collateral damage cases resulting from systemic medication therapies (antiresorptive drugs, immunotherapeutics) or irradiation, which may likewise lead to medication-related osteonecrosis of the mandible (MRONJ) or osteo(radio)necrosis with tumour-like segmental resection of the mandible, highlighting the value of an international database for these less frequent pathologies. Primary objectives are to describe the patient population and current treatment modalities, describe the outcomes and adverse events (AEs) for different treatment modalities, and identify potential predictors for successful autologous reconstruction of SMDs. Approximately 300 patients with a mandibular lesion resulting from bisphosphonate- and immunomodulatory drug-induced osteonecrosis of the mandible, ameloblastoma or osteosarcoma of the mandible, oral metastases related mandibular lesions indicated for segmental resection, or OSCC undergoing SMDR or intending to undergo one- or two-stage reconstruction will be prospectively recruited over a 36-month period. Baseline information, treatment details, and outcome measures will be documented. All treatments will be per the usual practice at participating sites. Outcome measures include clinical, patient-reported, and radiological outcomes; AEs related to the condition and/or treatment with a possible influence on the outcome will be recorded.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, University Hospital Tübingen, 72076 Tübingen, Germany.
- Department of Oral and Maxillofacial Surgery, University Hospital Leipzig, 04103 Leipzig, Germany.
- Department of Oral and Maxillofacial Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
- Universitätsklinikum Heidelberg, Mund-, Zahn-, Kieferklinik, 69120 Heidelberg, Germany.
- Klinikum der LMU München, 80337 München, Germany.
- Uniklinik RWTH Aachen, 52074 Aachen, Germany.
ORCID-Profile: Rüdiger M Zimmerer, Max Heiland, Julius Moratin, Ali Modabber, Philippe Korn, Andreas Naros, Florian Thieringer, Roderick Kim, Andreas Thor, Alberto Pereira, Henrique Messias, Nils-Claudius Gellrich
Förderung
- AO Foundation
- AO Foundation via the AO Innovation Translation Center
Zitieren
APA
Zimmerer, R. M., Pankow, T., Heiland, M., Moratin, J., Smolka, W., Modabber, A., Korn, P., Mejia Nieto, M., Naros, A., Thieringer, F., Fernandes, R., Kim, R., Weyh, A., Wolvius, E. B., Khan, M., Thor, A., Ebeling, M., Kanno, T., Pereira, A., …, & Gellrich, N. C. (2026). A Prospective, International, Multicentre Registry of Patients Undergoing Segmental Mandibular Defect Reconstruction After Mandibular Resection for Tumours and Drug-Induced Osteonecrosis: A Study Protocol. Craniomaxillofacial Trauma & Reconstruction, 19(1), 17. https://doi.org/10.3390/cmtr19010017
Vancouver
Zimmerer RM, Pankow T, Heiland M, Moratin J, Smolka W, Modabber A, et al. A Prospective, International, Multicentre Registry of Patients Undergoing Segmental Mandibular Defect Reconstruction After Mandibular Resection for Tumours and Drug-Induced Osteonecrosis: A Study Protocol. Craniomaxillofacial Trauma & Reconstruction. 2026;19(1):17. doi:10.3390/cmtr19010017
BibTeX
@article{Zimmerer2026,
author = {Zimmerer, Rüdiger M and Pankow, Tabea and Heiland, Max and Moratin, Julius and Smolka, Wenko and Modabber, Ali and Korn, Philippe and Mejia Nieto, Maria and Naros, Andreas and Thieringer, Florian and Fernandes, Rui and Kim, Roderick and Weyh, Ashleigh and Wolvius, Eppo B and Khan, Mohemmed and Thor, Andreas and Ebeling, Marcel and Kanno, Takahiro and Pereira, Alberto and Messias, Henrique and Gellrich, Nils-Claudius},
title = {A Prospective, International, Multicentre Registry of Patients Undergoing Segmental Mandibular Defect Reconstruction After Mandibular Resection for Tumours and Drug-Induced Osteonecrosis: A Study Protocol},
journal = {Craniomaxillofacial Trauma & Reconstruction},
year = {2026},
volume = {19},
number = {1},
pages = {17},
doi = {10.3390/cmtr19010017}
}
EUVIMED